Skip to main content
Eric Mullins, MD, Pediatric Hematology & Oncology, Cincinnati, OH

EricMullinsMD

Pediatric Hematology & Oncology Cincinnati, OH

Pediatric Anemia and Red Blood Cell Hematology, Pediatric Coagulation Disorder Hematology, Pediatric Platelet Disorder Hematology

Professor of Pediatrics, University of Cincinnati College of Medicine, Research Director, Hemophilia Treatment Center, Cincinnati Children's Hospital Medical Center

Dr. Mullins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mullins' full profile

Already have an account?

  • Office

    3333 Burnet Avenue
    MLC 7015
    Cincinnati, OH 45229
    Phone+1 513-517-2234
    Fax+1 513-803-5095

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2004 - 2007
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Pediatrics, 2001 - 2004
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2001
  • University of Missouri
    University of MissouriB.S., Biochemistry, Summa Cum Laude/Honors Scholar, 1993 - 1997

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2004 - 2026
  • IN State Medical License
    IN State Medical License 2021 - 2025
  • KY State Medical License
    KY State Medical License 2021 - 2025
  • American Board of Pediatrics Pediatrics
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Young Investigator Award International Society on Thrombosis and Haemostasis, 2009
  • Clinical Fellowship National Hemophilia Foundation, 2005
  • Elected to Alpha Omega Alpha 2000
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Urokinase plasminogen activator and receptor promote collagen-induced arthritis through expression in hematopoietic cells  
    Thornton S, Raghu H, Cruz C, Frederick MD, Palumbo JS, Mullins ES, Almholt K, Usher PA, and Matthew J. Flick, Blood Advances, 1/1/2017
  • Blood compatibility of heparin-inspired, lactose containing, polyureas depends on the chemistry of the polymer backbone  
    Huang Y, Shaw MA, Warmin MR, Mullins ES, and Ayres N, Polym. Chem., 1/1/2016

Books/Book Chapters

Abstracts/Posters

  • Plasminogen is protective from development of neuroinflammatory paralysis via preservation of fibrin matrices.
    ES Mullins, GRC, Plasminogen Activation & Extracellular Proteolysis, 1/1/2016
  • Thrombin and thrombin targets drives mortality and organ dysfunction in sickle cell disease.
    ES Mullins, FASEB SRC, Proteases in Hemostasis and Vascular Biology, 1/1/2011
  • Fibrin(ogen) deficiency ameliorates the severity of transfusion related acute lung injury in mice.
    ES Mullins, American Society of Hematology, 1/1/2009
  • Join now to see all

Lectures

  • Plasmin-Mediated Fibrinolysis Enables Macrophage Migration Via Liberation from Fibrin Interactions 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Menorrhagia and Hemostasis 
    1/1/2017
  • Platelet Disorders 
    1/1/2017
  • Join now to see all

Other

  • The SIPPET Trial: A Tale of Two Factors. 
    ES Mullins, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 1
    1/1/2017
  • A New Model for Treating Hemophilia A. 
    ES Mullins, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 2
    1/1/2016
  • Women and Bleeding Disorders. 
    Mullins TK and Mullins ES, Bloodline, A Newsletter for Members of the Bleeding Disorders Community, Volume 1
    1/1/2015

Professional Memberships